Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $10.3152W HIGH $50.38
Volume
800.75 K
Value Traded
37.29 M
Short % Float
9.53%
Days to Cover
5.5
-2.45%Week
+9.3%1 Month
+4.17%3 Month
+43.23%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
7.39 B
EPS (TTM)
1.70
P/E Ratio
27.46
Ent. Value
7.47 B
Total Shares
158.33 M
Float Shares
45.51 M
Insiders
71.26%
Institutions
31.20%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
PACS Catalyst Timeline
Dated clinical, regulatory and corporate events for PACS Group, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for PACS Group, Inc.
7Total events
0Upcoming
3Tier-1 (high impact)
2026 to 2026Coverage
Event history 5
▲AcquiredCorporate
Definitive agreement to acquire operations of 34 skilled nursing facilities from Eduro Healthcare
Past FDA Catalysts and PDUFA Decisions
How PACS actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
PACS Group, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every PACS program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Hancock MarkDirector, 10% Owner | Sell | -4,280 53,505,580 held | $50.02 | 10/29/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in PACS
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in PACS for Q2 2026. | ||||
Ownership Trends
PACS Short Interest
Shares sold short, counted twice a month.
9.53%
Short % of Float
of tradable shares sold short
4.3M
Shares Sold Short
+4.8% vs prior count
5.5 High
Days to Cover
trading days of normal volume to buy every short share back
790.4K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How PACS ranks across every disease it competes in
Competitive Position is a premium feature
See how PACS ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialPACS News
-PACS
Nov 3, 2026▲ +8.4%today
PACS Group, Inc. Reports Third Quarter 2026 Results
PACS Group, Inc. reported its third quarter 2026 results, showing a revenue of $1.50 billion, which is an 11.5% increase from the previous year. The net income also grew to $60.8 million, marking a 16.2% rise compared to the same quarter last year. This performance highlights the company's strong position in the post-acute healthcare sector.
Read more →-PACS
Oct 27, 2026PACS Group Schedules Third Quarter 2026 Earnings Release and Conference Call
PACS Group, Inc. will release its financial results for Q3 2026 on November 3, 2026. A conference call is scheduled for November 4, 2026, at 11:30 a.m. ET to discuss these results. Investors can access the call via webcast or phone. The company operates a significant number of post-acute care facilities across the U.S.
Read more →-PACS
Sep 30, 2026Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine
PACS Group, Inc. announced that 17 of its post-acute communities have been recognized by Newsweek Magazine as some of the Best Nursing Homes for 2027. The locations were ranked based on their state and category, showcasing PACS's commitment to high-quality care. This recognition is expected to enhance PACS's reputation in the healthcare industry.
Read more →-PACS
Sep 21, 2026PACS Group Announces Chief Legal Officer Transition
PACS Group announced the retirement of Chief Legal Officer John Mitchell, effective September 18, 2026. He will transition to a consultant role to aid in leadership changes. Patrick J. Murphy has been appointed as the new Chief Legal Officer, effective September 21, 2026, bringing over 20 years of legal experience to the company.
Read more →-PACS
Sep 14, 2026PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026
PACS Group, Inc. will present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026, in Nashville, TN. The presentation will feature key executives discussing the company's operations and growth strategy. This event reflects PACS's commitment to transparency and investor engagement.
Read more →-PACS
Sep 1, 2026PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities
PACS Group, Inc. has announced the acquisition of 32 skilled nursing facilities in Florida, which will be leased from Omega Healthcare Investors, Inc. These facilities collectively provide 4,049 licensed skilled nursing beds and are well-integrated into local healthcare systems. This move marks a significant expansion for PACS Group.
Read more →-PACS
Aug 4, 2026PACS Group, Inc. Reports Second Quarter 2026 Results
PACS Group, Inc. reported its financial results for the second quarter of 2026, highlighting a revenue increase of 9.1% year-over-year, reaching $1.43 billion. The company's net income also saw a substantial rise of 49.8%, amounting to $76.3 million compared to $51.0 million in the same period last year. These results reflect the company's robust growth in the post-acute healthcare sector.
Read more →-PACS
Jul 28, 2026PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Call
PACS Group, Inc. has announced its plans to release financial results for the second quarter of 2026 on August 4, 2026. Following this, a conference call will be held on August 5, 2026, at 11:30 a.m. ET to discuss the results. This initiative aims to keep investors informed and engaged.
Read more →-PACS
Jun 29, 2026▲ +6.8%on this news
PACS Group to Acquire Operations of 34 Facilities Across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah
PACS Group has announced its intention to acquire operations of 34 facilities located in Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah. This strategic move is aimed at expanding their operational footprint across multiple states. The acquisition reflects PACS Group's commitment to enhancing its service offerings in the healthcare sector.
Read more →-PACS
May 11, 2026▼ -5%on this news· ran to +22% by day 1
PACS Group, Inc. Reports First Quarter 2026 Results
PACS Group, Inc. has reported its first quarter results for 2026. However, the article provides minimal information, lacking key financial metrics or insights into the company's performance. The lack of detail raises concerns about transparency and investor confidence.
Read more →-PACS
May 5, 2026PACS Group Intends to Release First Quarter 2026 Earnings on Monday, May 11, 2026, and Host a Call to Discuss Financial Results on Tuesday, May 12, 2026
PACS Group has announced its plans to release its first quarter earnings for 2026 on May 11, 2026. Following the earnings release, the company will host a call on May 12, 2026, to discuss the financial results. This event is part of their regular financial reporting schedule.
Read more →-PACS
May 1, 2026PACS Group Announces Acquisition in Alaska; New Construction of a Skilled Nursing Community
PACS Group, Inc. announced the acquisition of Ridgeway Senior Living in Anchorage, Alaska, marking its fourth facility in the state. The company plans to construct a new 150-bed skilled nursing facility by 2028. This expansion aligns with PACS's mission to provide comprehensive post-acute care and support for residents and staff.
Read more →-PACS
Apr 27, 2026PACS Group, Inc. Announces the Appointment of Carey P. Hendrickson as Chief Financial Officer
PACS Group, Inc. has announced the appointment of Carey P. Hendrickson as the new Chief Financial Officer. This leadership change is expected to influence the company's financial strategies moving forward. Further details on Hendrickson's background and plans for the company were not disclosed in the announcement.
Read more →-PACS
Apr 27, 2026PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
PACS Group, Inc. has announced the retirement of co-founder and CFO Mark Hancock. His departure could raise concerns about the company's future leadership and financial direction. The company will need to address the transition to maintain investor confidence and operational stability.
Read more →-PACS
Nov 26, 2024Document PACS NYSE Notice Press Release PACS Group Announces Receipt of Notice of Late Filing from
PACS Group, Inc. recently announced that it received a Filing Delinquency Notification from the NYSE due to delays in filing its Quarterly Report on Form 10-Q for the quarter ending September 30, 2024. The delay is attributed to an ongoing investigation related to third-party allegations, which has hindered timely compliance. PACS Group has a six-month window to submit the report and regain compliance with NYSE regulations. Despite the current compliance issues, the company continues to operate a substantial network of post-acute healthcare facilities across the U.S.
Read more →About PACS Group, Inc.
Headquarters90 S. 400 W. SUITE 700, SALT LAKE CITY, UT, 84101
BIOPHARMAWATCH ELITE PLUS
Trade the next PACS catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime